{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-104019","form_type":"8-K","ticker":"RCEL","cik":"0001762303","company_name":"AVITA Medical, Inc.","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.912743+00:00","generated_at":"2026-05-17T19:42:10.581388+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"AVITA Medical appoints Michael Tarnoff to Board; Cary Vance becomes Board Chair","bullets":["Dr. Michael Tarnoff appointed as non-executive Director, effective August 6, 2025; most recently Chief Physician Executive and CEO at Tufts Medical Center.","Tarnoff receives $70,000 annual cash retainer, initial equity grant of $210,000 (30% options, 70% RSUs); annual grants subject to shareholder approval.","Cary Vance elected Board Chair, succeeding Lou Panaccio after more than 10 years of service; effective August 7, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-104019","json":"https://secwatch.observer/filing/0000950170-25-104019.json","markdown":"https://secwatch.observer/filing/0000950170-25-104019.md","text":"https://secwatch.observer/filing/0000950170-25-104019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1762303/000095017025104019/0000950170-25-104019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1762303/000095017025104019/rcel-20250806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T19:42:10.581388+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}